Zobrazeno 1 - 10
of 197
pro vyhledávání: '"C G, Moertel"'
Autor:
C. G. Moertel
Publikováno v:
JAMA: The Journal of the American Medical Association. 270:943-947
Autor:
C G Moertel
Publikováno v:
Journal of Clinical Oncology. 10:1986-1988
Publikováno v:
Journal of Clinical Oncology. 9:1322-1324
Autor:
R M, Goldberg, T R, Fleming, C M, Tangen, C G, Moertel, J S, Macdonald, D G, Haller, J A, Laurie
Publikováno v:
Annals of internal medicine. 129(1)
Follow-up testing after surgery for colon cancer is recommended principally to identify resectable recurrences, but data on the efficacy of, outcomes of, and optimal strategies for this testing are limited.To determine the relation between follow-up
Publikováno v:
Cancer. 79(4)
Octreotide, a long-acting somatostatin analogue, has demonstrated clinical utility in patients with carcinoid syndrome and malignant islet cell tumors of the pancreas. Prior studies have reported a greater than expected incidence of cholelithiasis in
Autor:
R M, Goldberg, C G, Moertel, H S, Wieand, J E, Krook, A J, Schutt, M H, Veeder, J A, Mailliard, R J, Dalton
Publikováno v:
Cancer. 76(6)
The purpose of this study was to determine by randomized, controlled, double-blind evaluation whether therapy with the somatostatin analogue, octreotide, would delay tumor progression and improve survival of patients with metastatic colorectal carcin
Publikováno v:
JAMA. 270(8)
To determine the effectiveness of carcinoembryonic antigen (CEA) monitoring in detecting surgically curable recurrence of colon cancer.Clinical data were collected from a national surgical adjuvant trial in which CEA monitoring was elective.Cancer ce
Autor:
C G, Kardinal, C G, Moertel, H S, Wieand, A J, Schutt, M J, O'Connell, K, Wright, M, Wiesenfeld, L K, Tschetter, J E, Krook
Publikováno v:
Cancer. 71(7)
Modest activity for doxorubicin has been detected repeatedly for the therapy of advanced hepatocellular carcinoma. Variable activity in this disease also has been documented for alpha-interferon. Preclinical data indicated the possibility that alpha-
Autor:
D A, Ahlquist, H S, Wieand, C G, Moertel, D B, McGill, C L, Loprinzi, M J, O'Connell, J A, Mailliard, J B, Gerstner, K, Pandya, R D, Ellefson
Publikováno v:
JAMA. 269(10)
To define the validity of fecal blood as a marker for colorectal neoplasia in the screening setting and to compare yields by Hemoccult and HemoQuant fecal occult blood screening tests.A multicenter masked comparison of fecal blood test results agains
Publikováno v:
The Yale Journal of Biology and Medicine
In 77 percent of patients suffering from a malignant carcinoid syndrome, administration of the somatostatin analog, octreotide (SMS 201-995, Sandostatin) induced clinical improvement coupled with a decrease in 24-hour urinary 5-hydroxyindole acetic a